Furthermore, a recent systematic review and meta-analysis by Badve et al. suggests that in CKD, interventions to reduce LVH through altering volume status are not consistently effective, and even where they do reduce LVH (for example through improving haemoglobin or renin-angiotensin blockade), no survival benefit has been seen75. This evidence concerns the gene REN and chronic kidney disease.